ClinicalTrials.govpublic full text
Long-Term Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Hypertension and Kidney Disease
safety, renal insufficiency, kidney diseases, hypertension, drug therapy, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1009222
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.